Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
923.90
+22.05 (2.44%)
Feb 17, 2025, 9:15 AM IST
Zydus Lifesciences Revenue
Zydus Lifesciences had revenue of 52.69B INR in the quarter ending December 31, 2024, with 16.96% growth. This brings the company's revenue in the last twelve months to 222.47B, up 16.94% year-over-year. In the fiscal year ending March 31, 2024, Zydus Lifesciences had annual revenue of 195.47B with 13.40% growth.
Revenue (ttm)
222.47B
Revenue Growth
+16.94%
P/S Ratio
4.18
Revenue / Employee
8.26M
Employees
26,921
Market Cap
929.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 195.47B | 23.10B | 13.40% |
Mar 31, 2023 | 172.37B | 21.28B | 14.08% |
Mar 31, 2022 | 151.10B | 7.06B | 4.90% |
Mar 31, 2021 | 144.04B | 1.50B | 1.06% |
Mar 31, 2020 | 142.53B | 10.88B | 8.26% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Fortis Healthcare | 75.61B |
Zydus Lifesciences News
- 14 hours ago - Zydus Lifesciences shares surge nearly 3% after US FDA issues no observations for Ambernath unit - Business Upturn
- 3 days ago - Zydus and Beihai Biotech sign strategic agreement for BEIZRAY product for the US market - Business Upturn
- 5 days ago - Zydus signs exclusive agreement with Synthon for a novel 505(B)(2) oncology product for US market - Business Upturn
- 12 days ago - Zydus Lifesciences Q3 FY25 Financial Results: Revenue grows 17% YoY to Rs 5269 crore, Profit surges 29.6% YoY - Business Upturn
- 22 days ago - Zydus Lifesciences chairman Pankaj R. Patel awarded Padma Bhushan for contributions to lifesciences - Business Upturn
- 4 weeks ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn
- 5 weeks ago - Zydus announces agreement with CVS Caremark to add Zituvio and combination products to its template formulary - Seeking Alpha
- 5 weeks ago - Zydus signs strategic agreement with CVS Caremark to add Zituvio , Zituvimet and ZituvimetTM to its template formulary - Business Upturn